You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
麗珠醫藥(01513.HK)根據建議採納的第一期持股計劃授出認購份額
格隆匯 04-09 07:02

格隆匯 4 月 9日丨麗珠醫藥(01513.HK)發佈公吿,2021年4月8日,董事會建議採納第一期持股計劃及管理辦法。第一期持股計劃及管理辦法須待股東於臨時股東大會通過特別決議案批准後,方可作實。持有人以及彼等的聯繫人須對有關批准建議採納第一期持股計劃及管理辦法的決議案放棄投票。

第一期持股計劃總人數80人,其中參與第一期持股計劃的董事(不含獨立非執行董事)、監事和高級管理人員9人,最終參與人員根據實際認購情況確定。持股5%以上股東及實際控制人不參與第一期持股計劃。第一期持股計劃的資金總額為人民幣11,746.1090萬元,全部為公司計提的專項基金。

第一期持股計劃所持有的股票總數累計不得超過目前公司股本總額的10%,單個員工所持第一期持股計劃份額所對應的股票總數累計不得超過目前公司股本總額的1%。第一期持股計劃存續期為48個月,自公司公吿第一期持股計劃最後一筆標的股票過户至第一期持股計劃名下時起計算。第一期持股計劃所獲標的股票的鎖定期為36個月,自公司公吿第一期持股計劃最後一筆標的股票過户至第一期持股計劃名下時起計算。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account